Ticker	Volume	Price	Price Delta
DJIA	15,338.10	-49.50	-0.32%
S&P 500	1,660.65	-8.51	-0.51%
Nasdaq	3,467.15	-34.98	-1.00%

Ticker

Volume

Price

Price Delta

DJIA

15,338.10

-49.50

-0.32%

S&P 500

1,660.65

-8.51

-0.51%

Nasdaq

3,467.15

-34.98

-1.00%

Ticker	Volume	Price	Price Delta
STOXX 50	2,835.01	+13.36	0.47%
FTSE 100	6,840.27	+36.40	0.53%
DAX	8,530.89	+58.69	0.69%

Ticker

Volume

Price

Price Delta

STOXX 50

2,835.01

+13.36

0.47%

FTSE 100

6,840.27

+36.40

0.53%

DAX

8,530.89

+58.69

0.69%

Ticker	Volume	Price	Price Delta
Nikkei	15,627.30	+246.24	1.60%
Hang Seng	23,261.10	-105.29	-0.45%
S&P/ASX 200	5,165.37	-14.69	-0.28%

Ticker

Volume

Price

Price Delta

Nikkei

15,627.30

+246.24

1.60%

Hang Seng

23,261.10

-105.29

-0.45%

S&P/ASX 200

5,165.37

-14.69

-0.28%

Exchange: Hong Kong
Sector: Consumer, Non-cyclical
Industry: Pharmaceuticals
Sub-Industry: Medical-Drugs

Hua Han Bio-Pharmaceutical Holdings Ltd

+ Add to Watchlist

587:HK

2.260 HKD 0.140 5.83%

Share this quote:

Post this quote on one of these sites:

Copy permanent URL

As of 04:01:04 ET on 05/22/2013.

Snapshot for Hua Han Bio-Pharmaceutical Holdings Ltd (587)

Open:	2.400	Day's Range:	2.240 - 2.400	Volume:	14,824,000
Previous Close:	2.400	52wk Range:	0.987 - 2.650	1-Yr Rtn:	+128.13%

Stock Chart for 587

No chart data available.

587:HK 2.260

2.400

Interactive 587 Chart

…

Previous Close

Key Statistics for 587

Current P/E Ratio (ttm)	10.5035
Estimated P/E(06/2013)	16.1429
Relative P/E vs. HSI	0.9934
Earnings Per Share (HKD) (ttm)	0.2152
Est. EPS (HKD) (06/2013)	0.1400
Est. PEG Ratio	-
Market Cap (M HKD)	7,164.41
Shares Outstanding (M)	3,170.09
30 Day Average Volume	16,549,250
Price/Book (mrq)	1.6414
Price/Sale (ttm)	4.7388
Dividend Indicated Gross Yield	1.25%
Cash Dividend (HKD)	0.0283
Last Dividend	01/02/2013
5 Year Dividend Growth	48.14%
Next Earnings Announcement	09/30/2013

mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 587

Revenue
Net Income (M/HKD)

Profit Margin (%)

Company Profile & Key Executives for 587

Hua Han Bio-Pharmaceutical Holdings Limited, through its subsidiaries, researches, develops, manufactures, and sells Chinese herbal pharmaceutical products primarily for women and the elderly under its Yeosure brand name. The Company also researches, develops, manufactures, and sells naturally-sourced anti-tumor medicines and western pharmaceutical products.